Pfizer Limited (PFIZER) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.156x

Based on the latest financial reports, Pfizer Limited (PFIZER) has a cash flow conversion efficiency ratio of 0.156x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs5.99 Billion ≈ $64.83 Million USD) by net assets (Rs38.48 Billion ≈ $416.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Pfizer Limited balance sheet independence to measure how much of total assets are equity-financed.

Pfizer Limited - Cash Flow Conversion Efficiency Trend (2005–2026)

This chart illustrates how Pfizer Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Pfizer Limited (PFIZER) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Pfizer Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pfizer Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
China Railway Hi-tech Industry Corp Ltd
SHG:600528
0.101x
ACME Solar Holdings Limited
NSE:ACMESOLAR
0.151x
Bank of Xi'An Co Ltd
SHG:600928
0.403x
eToro Group Ltd.
NASDAQ:ETOR
0.076x
Poco Holding Co Ltd
SHE:300811
0.018x
KANSAI PAINT SPON.ADR/1/2
F:KAP0
N/A
Shanghai Kingstar Winning Software
SHE:300253
-0.012x
Adaptive Biotechnologies Corp
NASDAQ:ADPT
-0.032x

Annual Cash Flow Conversion Efficiency for Pfizer Limited (2005–2026)

The table below shows the annual cash flow conversion efficiency of Pfizer Limited from 2005 to 2026. For the full company profile with market capitalisation and key ratios, see Pfizer Limited stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs42.03 Billion
≈ $454.53 Million
Rs11.44 Billion
≈ $123.67 Million
0.272x +73.94%
2025-03-31 Rs42.17 Billion
≈ $456.10 Million
Rs6.60 Billion
≈ $71.35 Million
0.156x +119.00%
2024-03-31 Rs35.96 Billion
≈ $388.84 Million
Rs2.57 Billion
≈ $27.78 Million
0.071x -35.59%
2023-03-31 Rs32.07 Billion
≈ $346.86 Million
Rs3.56 Billion
≈ $38.47 Million
0.111x -52.38%
2022-03-31 Rs28.64 Billion
≈ $309.78 Million
Rs6.67 Billion
≈ $72.14 Million
0.233x +30.42%
2021-03-31 Rs23.93 Billion
≈ $258.80 Million
Rs4.27 Billion
≈ $46.21 Million
0.179x +87.62%
2020-03-31 Rs33.95 Billion
≈ $367.21 Million
Rs3.23 Billion
≈ $34.95 Million
0.095x +193.03%
2019-03-31 Rs30.11 Billion
≈ $325.66 Million
Rs978.10 Million
≈ $10.58 Million
0.032x -73.73%
2018-03-31 Rs26.83 Billion
≈ $290.18 Million
Rs3.32 Billion
≈ $35.88 Million
0.124x -9.03%
2017-03-31 Rs24.19 Billion
≈ $261.59 Million
Rs3.29 Billion
≈ $35.56 Million
0.136x -16.22%
2016-03-31 Rs21.18 Billion
≈ $229.05 Million
Rs3.44 Billion
≈ $37.16 Million
0.162x +182.10%
2015-03-31 Rs19.73 Billion
≈ $213.37 Million
Rs1.13 Billion
≈ $12.27 Million
0.058x -71.41%
2014-03-31 Rs6.58 Billion
≈ $71.20 Million
Rs1.32 Billion
≈ $14.32 Million
0.201x +4060.27%
2013-03-31 Rs16.94 Billion
≈ $183.25 Million
Rs-86.07 Million
≈ $-930.79K
-0.005x -127.10%
2012-03-31 Rs13.05 Billion
≈ $141.10 Million
Rs244.59 Million
≈ $2.65 Million
0.019x -86.64%
2011-03-31 Rs11.63 Billion
≈ $125.82 Million
Rs1.63 Billion
≈ $17.66 Million
0.140x +86.88%
2010-03-31 Rs9.94 Billion
≈ $107.53 Million
Rs746.73 Million
≈ $8.08 Million
0.075x -71.54%
2009-03-31 Rs9.01 Billion
≈ $97.45 Million
Rs2.38 Billion
≈ $25.71 Million
0.264x +941.98%
2008-03-31 Rs6.50 Billion
≈ $70.26 Million
Rs164.53 Million
≈ $1.78 Million
0.025x -90.96%
2007-03-31 Rs4.40 Billion
≈ $47.56 Million
Rs1.23 Billion
≈ $13.32 Million
0.280x +2.51%
2006-03-31 Rs3.76 Billion
≈ $40.66 Million
Rs1.03 Billion
≈ $11.11 Million
0.273x +6.40%
2005-03-31 Rs3.40 Billion
≈ $36.72 Million
Rs872.08 Million
≈ $9.43 Million
0.257x --

About Pfizer Limited

NSE:PFIZER India Drug Manufacturers - General
Market Cap
$2.43 Billion
Rs224.83 Billion INR
Market Cap Rank
#5467 Global
#252 in India
Share Price
Rs4914.60
Change (1 day)
+1.88%
52-Week Range
Rs4404.90 - Rs5766.50
All Time High
Rs6318.30
About

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vi… Read more